CAR-T cell therapy and bispecific antibodies are advanced immunotherapies that help the immune system recognize and attack cancer in new ways. While both treatments use the body’s immune response, how they are given, how quickly they work, and what side effects to watch for can be very different. These short, plain-language videos explain how each therapy works, what the treatment process looks like, and important safety information, including symptoms that should prompt an urgent call to your care team. All content is reviewed by oncology professionals to help you feel informed, prepared, and confident throughout treatment.
CAR-T Cell Therapy & BiTEs Bispecific Antibodies
Bispecific Antibodies
This video explores one of the most exciting advancements in cancer therapy: BiTEs or bispecific antibodies. We'll break down how this powerful immunotherapy works as a "smart bridge," connecting your own immune cells directly to myeloma cells to launch a precise and powerful attack. Learn about this cutting-edge treatment and what it could mean for the future of myeloma care.
Educational content only. This video does not replace medical advice from your healthcare team.
CAR-T Cell Therapy
Welcome to the forefront of cancer treatment. This video explains CAR-T Cell Therapy, a revolutionary immunotherapy that supercharges your own immune system to fight back against cancer. We'll walk you through this groundbreaking process, often called a "living drug," where your own T-cells are collected, re-engineered in a lab to recognize and attack cancer cells, and then returned to your body to do their job.
Educational content only. This video does not replace medical advice from your healthcare team.
Cytokine Release Syndrome (CRS)
This video explains Cytokine Release Syndrome, or CRS, in a simple, clear way. CRS is an immune reaction that can occur with treatments such as CAR-T cell therapy and bispecific antibodies. We cover:
What CRS is and why it happens
When CRS typically occurs during treatment
Common symptoms, including fever, chills, low blood pressure, and breathing changes
How CRS is monitored and treated by the healthcare team
When patients and caregivers should call the care team or seek urgent care
Educational content only. This video does not replace medical advice from your healthcare team.
Immune Effector Cell–Associated Neurotoxicity Syndrome (ICANS)
This video explains Immune Effector Cell–Associated Neurotoxicity Syndrome, or ICANS, in a simple, clear way.
ICANS is a neurologic side effect that can occur with treatments such as CAR-T cell therapy and bispecific antibodies.
We cover:
What ICANS is and why it happens
When ICANS typically occurs during treatment
Common symptoms, including confusion, trouble speaking, headache, sleepiness, tremor, or changes in behavior
How ICANS is monitored and treated by the healthcare team
When patients and caregivers should call the care team or seek urgent care
Educational content only. This video does not replace medical advice from your healthcare team.